SCHEMBL267216

SCHEMBL267216

CCn1cc(N)c(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23248486 0.98 RECQL (0.49)
Hydrochloric Acid SCHEMBL2181433 0.98 RECQL (0.49)
SCHEMBL1663078 0.83 RECQL (0.37)
SCHEMBL28052581 0.79 RECQL (0.40)
SCHEMBL28892524 0.79
SCHEMBL6971482 0.77 ALDH1A1 (0.36)
SCHEMBL15651764 0.77 NOS2 (0.33)
SCHEMBL1559261 0.77 MEN1 (0.38)
SCHEMBL21939589 0.77 RECQL (0.33)
SCHEMBL116289 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101724-A1 AMINO PYRIMIDINE AND AMINO TRIAZINE ANALOGS FOR TREATING CANCER NEREID THERAPEUTICS INCORPORATED (US) 2026-05-15 WO disclosed
WO-2025215153-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2025-10-16 WO disclosed
US-20230203034-A1 IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS MERCK PATENT GMBH (DE) 2023-06-29 US disclosed
US-20230203034-A1 IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS MERCK PATENT GMBH (DE) 2023-06-29 US disclosed
CN-113717156-B EGFR inhibitor, preparation method and application thereof 南京红云生物科技有限公司 2023-05-09 CN disclosed
CN-113717156-A EGFR inhibitor, preparation method and application thereof 南京红云生物科技有限公司 2021-11-30 CN disclosed
US-11091475-B2 Methods and compositions for modulating splicing SKYHAWK THERAPEUTICS, INC. (US) 2021-08-17 US disclosed
US-20210198257-A1 IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS MERCK PATENT GMBH (DE) 2021-07-01 US disclosed
EP-3517536-B1 AMINOTRIAZINE DERIVATIVES USEFUL AS TANK-BINDING KINASE INHIBITOR COMPOUNDS GILEAD SCIENCES INC (US) 2021-05-05 EP disclosed
US-10975075-B2 Imidazolonylquinolines and the use thereof as ATM kinase inhibitors MERCK PATENT GMBH (DE) 2021-04-13 US disclosed
WO-2010066721-A2 TONICIZING COLORATION HENKEL AG & CO. KGAA (DE) 2010-06-17 WO disclosed
WO-2010060730-A1 HAIR COLOURING METHOD COMPRISING AFTERTREATMENT HENKEL AG & CO. KGAA (DE) 2010-06-03 WO disclosed
WO-2010029005-A2 HAIR PREPARATION COMPRISING SPIRULINA EXTRACT HENKEL AG & CO. KGAA (DE) 2010-03-18 WO disclosed
US-20090312314-A1 HETEROAROMATIC MONOAMIDES AS OREXININ RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-12-17 US disclosed
CN-101437811-A Quinoline derivatives ASTRAZENECA AB (SE) 2009-05-20 CN disclosed
US-20090076074-A1 QUINOLINE DERIVATIVES ASTRAZENECA AB (SE) 2009-03-19 US disclosed
WO-2007057079-A1 AZO DYES FOR COLOURING KERATIN-CONTAINING FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-05-24 WO disclosed
WO-2006087019-A1 AGENTS FOR COLOURING KERATIN CONTAINING FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-08-24 WO disclosed
EP-1567118-A1 HAIR-DYEING AGENT COMPRISING ENCAPSULATED CARE PRODUCTS Henkel Kommanditgesellschaft auf Aktien (DE) 2005-08-31 EP disclosed
WO-2004050048-A1 HAIR-DYEING AGENT COMPRISING ENCAPSULATED CARE PRODUCTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-06-17 WO disclosed